SCHEMBL5360407

SCHEMBL5360407

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C#N)c3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
DPP4 P27487 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
NR1H2 P55055 1/20 0.41
P4HB P07237 1/20 0.40
PGR P06401 1/20 0.39
SFRP1 Q8N474 1/20 0.38
BRD4 O60885 1/20 0.38
BRD2 P25440 1/20 0.38
BRD3 Q15059 1/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
TRIM24 O15164 1/20 0.38
MAPT P10636 1/20 0.38
PIK3CD O00329 1/20 0.37
ACLY P53396 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360412 1.00 HRH2 (0.41) HRH2HRH1DPP4DPP7NR1H2
SCHEMBL5367649 0.91 THRB (0.40) HRH2HRH1P4HBALDH1A1LMNA
SCHEMBL5367638 0.91 THRB (0.40) HRH2HRH1P4HBALDH1A1LMNA
SCHEMBL5363019 0.88 HTR1A (0.42) BRD4BRD2BRD3ALDH1A1LMNA
SCHEMBL5356429 0.88 HTR1A (0.42) BRD4BRD2BRD3ALDH1A1LMNA
SCHEMBL5356423 0.88 HTR1A (0.42) BRD4BRD2BRD3ALDH1A1LMNA
SCHEMBL5374256 0.84 DRD2 (0.46) PGRBRD4BRD2BRD3ALDH1A1
SCHEMBL5374249 0.84 DRD2 (0.46) PGRBRD4BRD2BRD3ALDH1A1
SCHEMBL5356019 0.84 KMT2A (0.43) DPP4DPP7BRD4BRD2BRD3
SCHEMBL5356013 0.84 KMT2A (0.43) DPP4DPP7BRD4BRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282592-B2 Resorcinol derivatives WARNER-LAMBERT COMPANY (US) 2007-10-16 US disclosed
US-20070122367-A1 RESORCINOL DERIVATIVES PFIZER INC. (US) 2007-05-31 US disclosed
US-7173052-B2 Resorcinol derivatives PFIZER INC. (US) 2007-02-06 US disclosed
US-20050282899-A1 Resorcinol for lightening skin removing color BRADLEY STUART E 2005-12-22 US disclosed
US-6852747-B2 Resorcinol derivatives PFIZER INC. (US) 2005-02-08 US disclosed
US-20030180236-A1 Resorcinol derivatives PFIZER PRODUCTS, INC. 2003-09-25 US disclosed
US-6590105-B2 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits WARNER-LAMBERT COMPANY 2003-07-08 US disclosed
US-20020114770-A1 Resorcinol derivatives PFIZER INC. 2002-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122367-A1 RESORCINOL DERIVATIVES LRAT, NQO1, ALDH1A2 HRH2 706/4885HRH1 484/4885DPP4 1407/4885
US-20030180236-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 HRH2 706/4885HRH1 484/4885DPP4 1407/4885
US-20050282899-A1 Resorcinol for lightening skin removing color RBP4, NQO1, ALDH1A2 HRH2 740/4885HRH1 634/4885DPP4 639/4885
US-20020114770-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 HRH2 706/4885HRH1 484/4885DPP4 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.